Study shows cognitive decline is not normal in aging

Finding opens door to prevention by showing older people with atherosclerosis or diabetes in combination with the ApoE4 gene are at much higher risk for memory loss, cognitive decline.

(Sacramento, Calif.) -- In a study that tracked changes in cardiovascular health and cognitive function in 5,888 community-dwelling senior citizens annually over a ten-year period, researchers at UC Davis School of Medicine and Medical Center say cognitive decline is not a normal part of aging for the majority of elderly people. In fact, only people with high levels of atherosclerosis or diabetes and also those with the apolipoprotein E4 gene associated with Alzheimer's disease are both at high risk for a decline in cognitive ability as they age. The results of the study are reported in the July 7 issue of the Journal of the American Medical Association.

"Seventy percent of individuals evaluated in this study showed no significant decline in cognitive function over the study period," says Mary N. Haan, director of the UC Davis Center for Aging and Health and lead author of the study. "We found that individuals whose cognitive ability remained constant during the study had two factors in common: they did not carry any of the apolipoprotein E4 genes, which is often associated with Alzheimer's disease, and they had little or no signs of diabetes or atherosclerosis."

In comparison, the researchers found that the greatest loss of cognitive ability occurred in people who had both high levels of atherosclerosis or diabetes and an Apo4E gene. These individuals were eight times more likely to show a decline in function compared to people with a low level of atherosclerosis and no genetic predisposition. Individuals with an E4 allele were three-to-four times more likely to show a decline in function than individuals without this genotype. And those with high levels of atherosclerosis were three times more likely to show a loss of function th

Contact: Carole Gan
University of California, Davis - Health System

Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: